High materiality7/10
Guardant Health price target raised to $200 from $185 at Morgan Stanley
Why it may matterVerify against the original reporting
target_up
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises GH target to $200; current price $162.99.
- Target: $200; Price: $162.99; Firm: Morgan Stanley
Key facts
- 01
Target: $200
- 02
Posted price: $162.99
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Kallum Titchmarsh
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.